Roundup Common Benefit Fund Appeal: Plaintiffs' Firms Ask Ninth Circuit to Undo the 8% MDL Assessment

The Roundup common benefit fund appeal, in brief

The Roundup common benefit fund appeal landed at the Ninth Circuit on Thursday, October 22, 2026, when plaintiffs' firms asked the court to reverse a ruling requiring them to pay 8% of their Roundup recoveries into the Multidistrict Litigation (MDL) leadership fund, arguing that U.S. District Judge Vince Chhabria disregarded a special master's recommendation. If the firms win, the assessment that has financed lead counsel's work in In re Roundup Products Liability Litigation, MDL No. 2741, since 2017 could be cut back or unwound, and the Ninth Circuit would be saying for the first time how far an MDL judge may go in taxing other lawyers' fees in this litigation.

According to Law360's report of the filing, the firms told the appellate court that the dispute "cries out for some appellate supervision." That phrase captures the posture: for five years, the Roundup fee fight has been fought almost entirely in front of one district judge, and the only prior trip to the Ninth Circuit ended without a ruling on the merits.

The appeal matters well beyond glyphosate. Every large mass tort docket, from talc to hair relaxer to Depo-Provera, funds its plaintiffs' steering committee through some version of a Common Benefit Fund. How the Ninth Circuit treats a judge who sets an assessment percentage, distributes the money against a special master's advice, and then enforces payment through the defendant will be read closely by MDL judges, lead counsel, and the individually retained firms who pay the bill.

What is the Roundup common benefit fund appeal about?

At its core, the appeal asks whether the 8% Roundup assessment, and the way the district court has administered it, can stand. The reporting available as of October 25, 2026 identifies two pillars of the firms' argument:

• The 8% contribution itself. The firms object to being required to contribute 8% of their recoveries to the fund. Law360 describes the obligation as 8% of "recovery fees"; the 2021 order that created the current holdback described it as 8% of a plaintiff's gross recovery. Which base applies changes the dollar burden on any individual firm considerably, and the distinction is one the Ninth Circuit may need to resolve.
• The special master. The firms argue the judge ignored a Special Master's recommendation. Law.com reported in August 2025 that when Judge Chhabria ordered $24.2 million in common benefit fees distributed to seven firms, a special master had recommended paying $0. Overriding a court-appointed fee adviser is not error in itself, since Federal Rule of Civil Procedure 53 lets a district judge adopt, modify, or reject a special master's recommendation, but the gap between $0 and $24.2 million is the kind of result appellants ask a reviewing court to scrutinize.

The names of the appellant firms, the precise order under review, and the briefing schedule were not available in public reporting at the time of writing. Monsanto is not the party paying the assessment, but the district court has drawn it into enforcement, as described below.

What is a common benefit fund in an MDL?

A common benefit fund is a pool of money, usually built by holding back a fixed percentage of every settlement or judgment in an MDL, that compensates the lead and committee lawyers whose work (discovery, expert development, bellwether trials, settlement negotiations) benefits every plaintiff, including those represented by firms that did none of that work. The holdback is typically split between a fee component and a cost-reimbursement component and is paid into a court-controlled account.

Courts have offered three justifications for the power to order such funds:

1. The Common Fund Doctrine, an equitable rule that lawyers who create or preserve a fund for others may be paid from it. Judge Chhabria found it a stretch to apply that doctrine to the Roundup arrangement.
2. Inherent case-management authority over the MDL and the lawyers appearing in it. Pretrial Order No. 236 located the "right source" of holdback power in the court's inherent managerial authority.
3. Consent, typically expressed through a participation agreement in which a firm outside the MDL agrees to pay the assessment in exchange for access to the MDL's work product. This is the basis the Ninth Circuit relied on most heavily in Bard IVC, discussed below.

The economic logic is the free-rider problem. Without an assessment, individually retained firms could settle on the strength of discovery and expert work they never paid for, leaving lead counsel uncompensated. The counter-argument, pressed by objectors in the Roundup docket, is that courts too often pay leadership for work that would have been done anyway and that a fixed percentage can overcompensate leadership when settlements are large.

How much do Roundup lawyers have to pay into the common benefit fund?

Roundup MDL plaintiffs' counsel must hold back 8% of a plaintiff's gross recovery for the common benefit fund under Pretrial Order No. 236, and that obligation applies to plaintiffs in the MDL. A 2026 stipulated dismissal filed in the MDL confirmed counsel's compliance with Pretrial Order No. 236, describing it as requiring an 8% holdback sent to the fund.

The 8% figure was a compromise. The fund was originally set up by a 2017 order that reached three groups, according to the Ninth Circuit's 2022 summary: claimants with cases in the MDL, non-MDL claimants whose counsel had at least one client in the MDL, and non-MDL claimants whose counsel signed participation agreements with lead counsel. In 2021, lead counsel asked Judge Chhabria to fix the holdback at 8.25% and to extend it to the recoveries of state court plaintiffs and of people who settled with Monsanto before filing any lawsuit at all. Press coverage at the time estimated the request could have generated roughly $800 million.

Judge Chhabria granted the motion only in part. In Pretrial Order No. 236, entered June 22, 2021, he set the holdback at 8% of gross recovery but limited the contribution requirement to plaintiffs in the MDL. He called the broader request "far-reaching," said lead counsel had "badly overreached," and rejected the idea that the free-rider concern was itself a source of judicial power. He also suggested a "far less intrusive" alternative: lead counsel could charge lawyers who actually use MDL work product directly, by contract, rather than asking the court to tax recoveries in cases it does not control.

Who received the Roundup common benefit fees?

The fee award went to seven plaintiffs' firms. According to Law.com's August 4, 2025 report, Judge Chhabria ordered $24.2 million in common benefit fees distributed to the seven firms that did the largest share of the work, despite a special master's recommendation of $0.

The allocation was contested long before it reached the Ninth Circuit:

• 2024 objections. When the MDL fee committee proposed an allocation in early 2024, several firms objected that the co-lead firms were awarding about 81% of the fund to themselves. The fee committee replied on February 16, 2024. Reporting at the time described a revised common benefit request of about $20.23 million, a figure that does not exactly match the later $24.2 million award; the available sources do not reconcile the two.
• Redistribution. In a January 15 order following the special master's report, Judge Chhabria said he remained "open to arguments" for redistributing the fund and invited objections.
• 2025 refund requests. The Daily Journal reported in March 2025 that two firms that represented Roundup plaintiffs asked the court to refund their contributions to the roughly $24 million paid to lead counsel, or to rescind or revise the distribution order.
• 2025 enforcement. On August 1, 2025, after a July 31 letter from Monsanto attorney Anthony Martinez of Shook, Hardy & Bacon identified 37 firms that had not paid their 8% assessment, Judge Chhabria ordered Monsanto to contact the heads of those firms and threatened sanctions.
• 2026 compliance order. In April 2026, an order regarding compliance with Pretrial Order No. 332 directed Monsanto and lead plaintiffs' counsel to work together on an update about compliance with the common benefit fund requirement and to recommend which firms, if any, are subject to that order.

The use of the defendant as a collection agent is unusual. It reflects a practical reality: Monsanto controls the settlement payments, so it is best placed to withhold the assessment before money reaches plaintiffs' counsel.

Can the Ninth Circuit hear an appeal of an MDL common benefit order?

It can if the order is final or falls within an exception, and that threshold question already sank one Roundup fee appeal. On November 3, 2022, in an unpublished memorandum in No. 21-16228, the Ninth Circuit dismissed lead counsel's appeal of Pretrial Order No. 236 for lack of jurisdiction. The panel held the 2021 order was not a final decision because it did not resolve the merits of the litigation or conclusively determine the common benefit fee issues, and it held the collateral order doctrine did not apply because, while the question was separate from the merits, the order was not effectively unreviewable after final judgment.

The 2022 dismissal was a loss for lead counsel, who had wanted the assessment extended to non-MDL plaintiffs. The 2026 appeal comes from the opposite direction, from firms that want to pay less, and the procedural setting appears to have changed. The fee distribution has been made, enforcement orders have issued, and thousands of MDL cases have been resolved, dismissed, or remanded. The Judicial Panel on Multidistrict Litigation (JPML) reported 1,104 actions pending in MDL 2741 on October 1, 2026, down from 3,925 a month earlier and from 5,324 transferred into the docket since 2016. Whether a distribution or enforcement order is now final as to the appellant firms, or reviewable on another basis, is likely to be the first question the panel addresses, and the answer will matter to every firm deciding when to challenge a common benefit assessment.

What did the Ninth Circuit decide in Bard IVC about common benefit fees?

In In re Bard IVC Filters Products Liability Litigation, No. 22-15872, a published opinion issued August 24, 2023, the Ninth Circuit affirmed a District of Arizona order requiring common benefit holdbacks from recoveries outside the MDL. The panel held that such an order is proper when claimants' counsel voluntarily consents to the district court's authority by signing or otherwise entering into a participation agreement, the agreement is incorporated into a court order, and counsel receives access to common benefit work product as a result. The court described the order as within the district court's authority to regulate the conduct of MDL counsel and parties.

The district court in Bard (reported at 603 F. Supp. 3d 822) had relied on four grounds: 28 U.S.C. § 1407, inherent power, consent, and the Common Fund Doctrine. It distinguished Judge Chhabria's 2021 Roundup ruling, which had concluded that neither the common fund doctrine nor docket-control power justified taxing a nonparty merely because the nonparty hired a lawyer with a client in the MDL. One commentator noted at the time that Bard appeared to aggravate an existing split among the circuits over common benefit assessments on non-MDL cases.

Bard gives the Roundup panel a framework but not an answer. It addressed whether non-MDL recoveries could be taxed with consent. The 2026 Roundup appeal, as reported, concerns MDL plaintiffs' counsel, whose cases sit squarely within the court's management authority, and turns instead on the size of the assessment and the process used to distribute it.

Roundup common benefit fund timeline

Date	Event	Source
2016	JPML centralizes Roundup cases before Judge Chhabria in the Northern District of California as MDL No. 2741	JPML
2017	Common benefit order covers MDL claimants, non-MDL claimants whose counsel had an MDL client, and participation-agreement signers	Ninth Circuit memorandum, No. 21-16228
June 22, 2021	Pretrial Order No. 236 rejects 8.25% holdback on state court and pre-suit recoveries; sets 8% of gross recovery for MDL plaintiffs	PTO 236
Nov. 3, 2022	Ninth Circuit dismisses lead counsel's appeal for lack of jurisdiction	No. 21-16228
Aug. 24, 2023	Ninth Circuit's Bard IVC opinion upholds consent-based holdbacks on non-MDL recoveries	No. 22-15872
Feb. 16, 2024	Fee committee replies to objections that co-leads took about 81% of the fund	HarrisMartin
March 2025	Two firms seek refunds of their contributions to the roughly $24 million paid to lead counsel	Daily Journal
Aug. 1, 2025	Judge orders Monsanto to contact heads of 37 firms that had not paid the 8%; $24.2 million already awarded to seven firms over a special master's $0 recommendation	Law.com
April 2026	Order on compliance with Pretrial Order No. 332 seeks joint compliance update from Monsanto and lead counsel	Leagle
June 25, 2026	Monsanto Co. v. Durnell holds 7-2 that FIFRA preempts label-based failure-to-warn claims	Supreme Court
Oct. 1, 2026	1,104 actions pending in MDL 2741	JPML
Oct. 22, 2026	Plaintiffs' firms ask Ninth Circuit to reverse the 8% contribution ruling	Law360

How Durnell and the class settlement change the stakes

The fee appeal is unfolding as the Roundup litigation changes shape. The Supreme Court's 7-2 decision in Monsanto Co. v. Durnell on June 25, 2026 held that FIFRA preempts state failure-to-warn claims that would require a cancer warning missing from the EPA-approved label, and Judge Chhabria has since invited amicus briefing on whether negligence, design defect, and warranty claims under six states' laws survive. Separately, the proposed $7.25 billion King v. Monsanto class settlement, which would resolve current and future claims, awaits a final approval ruling from Judge Timothy Boyer in the Circuit Court of the City of St. Louis, where class counsel have requested $675 million in fees from inside the fund.

Those developments compress the common benefit question. A shrinking federal docket means fewer future recoveries for the 8% to attach to, which raises the importance of money already collected. A state court class settlement with its own fee award raises an obvious question about overlap: whether recoveries routed through the Missouri class would carry an MDL assessment at all is a matter the available reporting does not resolve, and Pretrial Order No. 236's limitation to MDL plaintiffs suggests many would not. If the Ninth Circuit orders refunds or a reallocation, the leadership firms that received the $24.2 million would bear the exposure, not Monsanto.

What it means for plaintiffs' firms, lead counsel, funders and defendants

For individually retained PI firms. The appeal is the clearest test yet of whether firms that pay an assessment can obtain appellate review of how it is set and distributed. Firms in other MDLs should track whether the Ninth Circuit finds jurisdiction; if it does not, the practical lesson is that challenges must be preserved and pursued after a final judgment in the firm's own cases. Firms that signed participation agreements should assume that Bard IVC makes those contracts enforceable in this circuit.

For lead counsel and fee committees. A special master recommendation of $0 followed by a $24.2 million award invites the argument that the district court's process was inadequate. Fee committees elsewhere may respond by building a more detailed record of contemporaneous time and lodestar, by securing special master findings that support the requested amount, or by negotiating participation agreements up front rather than relying on court-ordered percentages.

For litigation funders. Third-Party Litigation Funding returns in mass torts are calculated on net attorney fees. An assessment that can be raised, lowered, or redistributed years after a settlement adds a variable that underwriting models often treat as fixed. A reversal could return money to funded firms; affirmance would confirm that the full 8% should be modeled as a cost.

For defendants. Monsanto's role as collector shows that defendants can be ordered to police plaintiffs' fee obligations. Defense counsel negotiating inventory settlements in any MDL should address common benefit holdbacks expressly in settlement agreements and allocate responsibility for any withholding the court later orders.

For MDL judges. The appeal may produce guidance on the standard of review for common benefit distributions and on how much weight a special master's fee recommendation carries. Either outcome will shape how courts structure orders under the new Federal Rule of Civil Procedure 16.1 conferences, where the court and parties are expected to address how leadership counsel will be compensated.

This analysis is not legal advice.

FAQ

What is the Roundup common benefit fund appeal?

It is a Ninth Circuit appeal in which plaintiffs' firms, in an October 22, 2026 brief, ask the court to reverse a ruling in the Roundup MDL that requires them to contribute 8% of their recoveries to the common benefit fund, arguing that Judge Chhabria disregarded a special master's recommendation.

Why are plaintiffs' firms appealing the Roundup 8% common benefit assessment?

They argue the assessment and its administration lack adequate support, pointing in particular to the special master's recommendation, which the district court did not follow. Law.com reported that the special master had recommended $0 in common benefit fees, while the court awarded $24.2 million to seven firms.

Does the Roundup common benefit fund apply to state court cases?

Generally no. Pretrial Order No. 236 rejected lead counsel's 2021 request to tax state court recoveries and pre-suit settlements and limited the 8% holdback to plaintiffs in the MDL, although the original 2017 order had reached some non-MDL claimants through their lawyers' MDL clients or participation agreements.

Can the Ninth Circuit review a common benefit fee order before the MDL ends?

Only if the order is final or fits an exception. In 2022 the Ninth Circuit dismissed an earlier Roundup fee appeal because the holdback order was not final and the collateral order doctrine did not apply; the current appeal will likely have to clear the same threshold.

What did Bard IVC hold about common benefit fees?

In Bard IVC (2023), the Ninth Circuit held that a district court may require common benefit holdbacks from non-MDL recoveries when counsel consented through a participation agreement incorporated into a court order and gained access to the MDL's work product.

Who has to pay if the Ninth Circuit reverses?

No court has said. As a practical matter, any refund or reallocation ordered after a reversal would most likely be drawn from the common benefit fund and the leadership firms paid from it rather than from Monsanto, though the remedy would be for the district court to fashion on remand.